Genprex Secures Canadian Patent for Innovative Cancer Therapy Combining Reqorsa® with PD-1 and PD-L1 Antibodies#Canada#Austin#cancer_therapy#Genprex#Reqorsa
Genprex Secures Canadian Patent for Innovative Cancer Therapy Combining Reqorsa® with PD-1 and PD-L1 Antibodies
Genprex, Inc. has received a significant patent from the Canadian Intellectual Property Office, enhancing its position in cancer therapy development through Reqorsa® Gene Therapy.
third-news.com
June 22, 2026 at 1:28 PM
Genprex Secures Canadian Patent for Innovative Cancer Therapy Combining Reqorsa® with PD-1 and PD-L1 Antibodies#Canada#Austin#cancer_therapy#Genprex#Reqorsa
Genprex's Reqorsa® Gene Therapy Shows Promising Biomarker Data at 2026 ASCO Annual Meeting#United_States#Austin#Genprex#Reqorsa#Biomarkers
Genprex's Reqorsa® Gene Therapy Shows Promising Biomarker Data at 2026 ASCO Annual Meeting
Genprex, Inc. presented new clinical data indicating that biomarkers can predict response to Reqorsa® gene therapy in lung cancer at the ASCO 2026.
third-news.com
May 26, 2026 at 12:12 PM
Genprex's Reqorsa® Gene Therapy Shows Promising Biomarker Data at 2026 ASCO Annual Meeting#United_States#Austin#Genprex#Reqorsa#Biomarkers
Genprex to Showcase Acclaim-3 Trial Design Evaluating Reqorsa® for Lung Cancer at ASCO 2025#United_States#Chicago#Genprex#Reqorsa#ASCO2025
Genprex to Showcase Acclaim-3 Trial Design Evaluating Reqorsa® for Lung Cancer at ASCO 2025
Genprex will present the Acclaim-3 clinical trial design for its Reqorsa® gene therapy targeting extensive stage small cell lung cancer at the ASCO Annual Meeting in 2025.
third-news.com
May 29, 2025 at 11:21 AM
Genprex to Showcase Acclaim-3 Trial Design Evaluating Reqorsa® for Lung Cancer at ASCO 2025#United_States#Chicago#Genprex#Reqorsa#ASCO2025
Thoughts on this? >> Genprex Collaborators to Present Positive Preclinical Data
on the Use of Reqorsa® Gene Therapy for the Treatment of Lung
Cancer at the 2025 AACR… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #biotech #healthcare
on the Use of Reqorsa® Gene Therapy for the Treatment of Lung
Cancer at the 2025 AACR… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #biotech #healthcare
Genprex Collaborators to Present Positive Preclinical Data
on the Use of Reqorsa® Gene Therapy for the Treatment of Lung
Cancer at the 2025 AACR Annual Meeting - Star Local Media
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting Star Local Media
dlvr.it
March 28, 2025 at 8:31 AM
Thoughts on this? >> Genprex Collaborators to Present Positive Preclinical Data
on the Use of Reqorsa® Gene Therapy for the Treatment of Lung
Cancer at the 2025 AACR… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #biotech #healthcare
on the Use of Reqorsa® Gene Therapy for the Treatment of Lung
Cancer at the 2025 AACR… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #biotech #healthcare
Just In: ( NASDAQ: #GNPX ) Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma
#StockMarket #News
#StockMarket #News
October 28, 2024 at 4:15 PM
#GNPX Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
https://www.stocktitan.net/news/GNPX/genprex-receives-patent-grant-from-the-israel-patent-office-for-the-izw7smvf1ttm.html
https://www.stocktitan.net/news/GNPX/genprex-receives-patent-grant-from-the-israel-patent-office-for-the-izw7smvf1ttm.html
Israel grants Genprex cancer-therapy patent tied to PD-1 drugs
The grant adds Israel to patents already issued in the U.S., Europe, Japan and other markets, extending protection for its cancer combo.
www.stocktitan.net
April 30, 2026 at 12:00 PM
#GNPX Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
https://www.stocktitan.net/news/GNPX/genprex-receives-patent-grant-from-the-israel-patent-office-for-the-izw7smvf1ttm.html
https://www.stocktitan.net/news/GNPX/genprex-receives-patent-grant-from-the-israel-patent-office-for-the-izw7smvf1ttm.html
🚀 Exciting times for #GNPX! Trading at $0.2873 with no volume today, but watch out for the REQORSA® gene therapy presentation on Oct 25, 2025! 📈 Mixed signals: RSI neutral, MACD bullish. Consider LONG if it breaks $0.30, targeting $0.35 & $0.40. Stop loss at $0.25. Biotech buzz! #FeetrAI
October 21, 2025 at 1:01 PM
🚨 $GNPX
On June 22, 2026, Genprex, Inc. issued a press release in which it announced that the Canadian Intellectual Property Office has issued a Notice of Allowance to Genprex for a patent covering the use of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with either PD-1 or PD-L...
On June 22, 2026, Genprex, Inc. issued a press release in which it announced that the Canadian Intellectual Property Office has issued a Notice of Allowance to Genprex for a patent covering the use of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with either PD-1 or PD-L...
SEC Filing: GNPX
Click to view the official SEC document.
www.sec.gov
June 22, 2026 at 1:02 PM
🚨 $GNPX
On June 22, 2026, Genprex, Inc. issued a press release in which it announced that the Canadian Intellectual Property Office has issued a Notice of Allowance to Genprex for a patent covering the use of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with either PD-1 or PD-L...
On June 22, 2026, Genprex, Inc. issued a press release in which it announced that the Canadian Intellectual Property Office has issued a Notice of Allowance to Genprex for a patent covering the use of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with either PD-1 or PD-L...
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - BioSpace: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers BioSpace
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - BioSpace
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers BioSpace
news.google.com
November 20, 2025 at 12:00 AM
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - BioSpace: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers BioSpace
USPTO grants patent to Genprex’s Reqorsa gene therapy - Yahoo: USPTO grants patent to Genprex’s Reqorsa gene therapy Yahoo
USPTO grants patent to Genprex’s Reqorsa gene therapy - Yahoo
USPTO grants patent to Genprex’s Reqorsa gene therapy Yahoo
news.google.com
November 19, 2025 at 10:53 AM
USPTO grants patent to Genprex’s Reqorsa gene therapy - Yahoo: USPTO grants patent to Genprex’s Reqorsa gene therapy Yahoo
USPTO grants patent to Genprex’s Reqorsa gene therapy - Pharmaceutical Technology: USPTO grants patent to Genprex’s Reqorsa gene therapy Pharmaceutical Technology
USPTO grants patent to Genprex’s Reqorsa gene therapy - Pharmaceutical Technology
USPTO grants patent to Genprex’s Reqorsa gene therapy Pharmaceutical Technology
news.google.com
November 19, 2025 at 10:34 AM
USPTO grants patent to Genprex’s Reqorsa gene therapy - Pharmaceutical Technology: USPTO grants patent to Genprex’s Reqorsa gene therapy Pharmaceutical Technology
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - PR Newswire: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers PR Newswire
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - PR Newswire
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers PR Newswire
news.google.com
November 18, 2025 at 12:49 PM
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - PR Newswire: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers PR Newswire
Genprex Secures U.S. Patent for Reqorsa® Therapy - TipRanks: Genprex Secures U.S. Patent for Reqorsa® Therapy TipRanks
Genprex Secures U.S. Patent for Reqorsa® Therapy - TipRanks
Genprex Secures U.S. Patent for Reqorsa® Therapy TipRanks
news.google.com
November 18, 2025 at 12:31 PM
Genprex Secures U.S. Patent for Reqorsa® Therapy - TipRanks: Genprex Secures U.S. Patent for Reqorsa® Therapy TipRanks
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - Yahoo Finance: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers Yahoo Finance
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - Yahoo Finance
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers Yahoo Finance
news.google.com
November 18, 2025 at 12:18 PM
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - Yahoo Finance: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers Yahoo Finance
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - StreetInsider: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers StreetInsider
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - StreetInsider
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers StreetInsider
news.google.com
November 18, 2025 at 12:05 PM
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers - StreetInsider: Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers StreetInsider
Genprex Announces European Patent Intent for Reqorsa® Gene Therapy - TradingView: Genprex Announces European Patent Intent for Reqorsa® Gene Therapy TradingView
Genprex Announces European Patent Intent for Reqorsa® Gene Therapy - TradingView
Genprex Announces European Patent Intent for Reqorsa® Gene Therapy TradingView
news.google.com
November 4, 2025 at 1:02 PM
Genprex Announces European Patent Intent for Reqorsa® Gene Therapy - TradingView: Genprex Announces European Patent Intent for Reqorsa® Gene Therapy TradingView
Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer - MarketScreener: Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer MarketScreener
Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer - MarketScreener
Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer MarketScreener
news.google.com
November 4, 2025 at 12:58 PM
Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer - MarketScreener: Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer MarketScreener
Genprex Secures European Patent for Reqorsa® Therapy - TipRanks: Genprex Secures European Patent for Reqorsa® Therapy TipRanks
Genprex Secures European Patent for Reqorsa® Therapy - TipRanks
Genprex Secures European Patent for Reqorsa® Therapy TipRanks
news.google.com
November 4, 2025 at 12:40 PM
Genprex Secures European Patent for Reqorsa® Therapy - TipRanks: Genprex Secures European Patent for Reqorsa® Therapy TipRanks